FDS
VRTX icon

Freedom Day Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Freedom Day Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.64M Sell
5,915
-112
-2% -$52.2K 0.71% 47
2025
Q4 		$2.73M Buy
6,027
+213
+4% +$91.8K 0.74% 46
2025
Q3 		$2.28M Buy
5,814
+100
+2% +$41.8K 0.62% 57
2025
Q2 		$2.54M Sell
5,714
-127
-2% -$58.5K 0.76% 47
2025
Q1 		$2.83M Sell
5,841
-58
-1% -$27K 0.87% 32
2024
Q4 		$2.38M Sell
5,899
-10
-0.2% -$4.63K 0.71% 42
2024
Q3 		$2.75M Buy
5,909
+18
+0.3% +$8.65K 0.85% 32
2024
Q2 		$2.76M Buy
5,891
+237
+4% +$103K 0.93% 26
2024
Q1 		$2.36M Sell
5,654
-54
-0.9% -$22.8K 0.84% 35
2023
Q4 		$2.32M Buy
5,708
+986
+21% +$364K 0.91% 30
2023
Q3 		$1.64M Buy
4,722
+115
+2% +$40.2K 0.72% 47
2023
Q2 		$1.62M Buy
4,607
+176
+4% +$59.3K 0.72% 51
2023
Q1 		$1.4M Buy
4,431
+629
+17% +$189K 0.66% 59
2022
Q4 		$1.1M Buy
+3,802
New +$1.16M 0.55% 64
2021
Q2 		– Sell
-1,707
Closed -$367K – 121
2021
Q1 		$367K Buy
1,707
+258
+18% +$56.7K 0.2% 87
2020
Q4 		$342K Sell
1,449
-2,880
-67% -$661K 0.19% 85
2020
Q3 		$1.17M Sell
4,329
-103
-2% -$28.4K 0.69% 62
2020
Q2 		$1.29M Buy
+4,432
New +$1.2M 0.85% 60

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Freedom Day Solutions's VRTX Position: Q1 2026 in Review

Freedom Day Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q1 2026, selling an estimated $52.2K and leaving 5,915 shares worth $2.64M. The position accounts for 0.71% of the portfolio, ranked #47.

Freedom Day Solutions first reported a position in VRTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $2.83M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Freedom Day Solutions held 5,915 shares of Vertex Pharmaceuticals worth $2.64M as of Q1 2026.
  • Freedom Day Solutions sold 112 Vertex Pharmaceuticals shares in Q1 2026, an estimated $52.2K.
  • Vertex Pharmaceuticals made up 0.71% of Freedom Day Solutions's portfolio in Q1 2026, its #47 holding.
  • Freedom Day Solutions first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • Freedom Day Solutions's Vertex Pharmaceuticals position peaked at $2.83M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Freedom Day Solutions's 13F filing for Q1 2026, filed 5 May 2026.